[go: up one dir, main page]

BR9915703B1 - mutante do vìrus da raiva recombinante, e, vacina anti-rábica atenuada viva. - Google Patents

mutante do vìrus da raiva recombinante, e, vacina anti-rábica atenuada viva.

Info

Publication number
BR9915703B1
BR9915703B1 BRPI9915703-9A BR9915703A BR9915703B1 BR 9915703 B1 BR9915703 B1 BR 9915703B1 BR 9915703 A BR9915703 A BR 9915703A BR 9915703 B1 BR9915703 B1 BR 9915703B1
Authority
BR
Brazil
Prior art keywords
rabies
live attenuated
recombinant
virus mutant
vaccine
Prior art date
Application number
BRPI9915703-9A
Other languages
English (en)
Other versions
BR9915703A (pt
Inventor
Teshome Mebatsion
Karl Klaus Conzelmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9915703A publication Critical patent/BR9915703A/pt
Publication of BR9915703B1 publication Critical patent/BR9915703B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI9915703-9A 1998-11-27 1999-11-19 mutante do vìrus da raiva recombinante, e, vacina anti-rábica atenuada viva. BR9915703B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204001 1998-11-27
PCT/EP1999/009101 WO2000032755A1 (en) 1998-11-27 1999-11-19 Stable, attenuated rabies virus mutants and live vaccines thereof

Publications (2)

Publication Number Publication Date
BR9915703A BR9915703A (pt) 2001-08-14
BR9915703B1 true BR9915703B1 (pt) 2012-09-04

Family

ID=8234392

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9915703-9A BR9915703B1 (pt) 1998-11-27 1999-11-19 mutante do vìrus da raiva recombinante, e, vacina anti-rábica atenuada viva.

Country Status (16)

Country Link
US (1) US6719981B1 (pt)
EP (1) EP1131414B1 (pt)
AR (1) AR021406A1 (pt)
AT (1) ATE356202T1 (pt)
AU (1) AU1386100A (pt)
BR (1) BR9915703B1 (pt)
CA (1) CA2352231C (pt)
CY (1) CY1106570T1 (pt)
DE (1) DE69935445T2 (pt)
DK (1) DK1131414T3 (pt)
ES (1) ES2283150T3 (pt)
ID (1) ID28968A (pt)
IL (2) IL143149A0 (pt)
PT (1) PT1131414E (pt)
TR (1) TR200101445T2 (pt)
WO (1) WO2000032755A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2257505T3 (es) 2001-04-23 2006-08-01 Akzo Nobel N.V. Mutantes de virus de la rabia atenuados y vacunas vivas correspondientes.
JP2005510249A (ja) 2001-07-20 2005-04-21 ザ ユニヴァーシティ オブ ジョージア リサーチファウンデーション， インク． 狂犬病に対するワクチン接種と中枢神経系における遺伝子治療のためのリン酸化部位において核蛋白質が変異した弱毒化狂犬病ウイルス
CA2943039C (en) 2005-10-14 2018-11-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Rabies virus compositions and methods
US7785874B2 (en) * 2007-01-11 2010-08-31 The Salk Institute For Biological Studies Compositions and methods for monosynaptic transport
TW200907058A (en) * 2007-05-30 2009-02-16 Wyeth Corp Raccoon poxvirus expressing rabies glycoproteins
CA2826594C (en) 2011-02-03 2019-09-17 The Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Multivalent vaccines for rabies virus and filoviruses
CN103865889B (zh) * 2014-04-03 2015-02-25 深圳市卫光生物制品股份有限公司 狂犬病病毒ctn鸡胚细胞适应株
EP4104854A3 (en) 2016-04-04 2023-03-08 The United States of America as represented by the Secretary of the Department of Health and Human Services Multivalent vaccines for rabies virus and coronaviruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580176B1 (fr) * 1985-04-12 1988-02-26 Centre Nat Rech Scient Vaccin antirabique avirulent
FR2633832B1 (fr) * 1988-07-05 1991-05-31 Virbac Vaccin antirabique avirulent
FR2693655B1 (fr) * 1992-07-20 1994-10-14 Virbac Vaccin antirabique avirulent.
SE0002498D0 (sv) 2000-07-03 2000-07-03 Stefan Schwartz Papillomavirus vaccine
US20050247051A1 (en) 2001-12-10 2005-11-10 Donaldson Company, Inc. Exhaust treatment control system for an internal combustion engine
DE102004009653A1 (de) 2004-02-27 2005-09-22 Cycos Ag Kommunikationsserver und Verfahren zum Aufbau und Betrieb einer Konferenz-Kommunikationsverbindung

Also Published As

Publication number Publication date
DE69935445T2 (de) 2007-11-29
TR200101445T2 (tr) 2001-10-22
CA2352231C (en) 2010-06-01
DK1131414T3 (da) 2007-06-18
ATE356202T1 (de) 2007-03-15
US6719981B1 (en) 2004-04-13
PT1131414E (pt) 2007-04-30
DE69935445D1 (de) 2007-04-19
ES2283150T3 (es) 2007-10-16
IL143149A (en) 2007-12-03
EP1131414B1 (en) 2007-03-07
ID28968A (id) 2001-07-19
EP1131414A1 (en) 2001-09-12
IL143149A0 (en) 2002-04-21
AR021406A1 (es) 2002-07-17
CY1106570T1 (el) 2012-01-25
AU1386100A (en) 2000-06-19
CA2352231A1 (en) 2000-06-08
BR9915703A (pt) 2001-08-14
WO2000032755A1 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
AU5562798A (en) Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus.
ATE287728T1 (de) Adjuvierte rekombinante lebendimpfstoffe gegen influenza- oder herpesviren
BR9710012B1 (pt) vacina veterinária viva recombinante e fórmula de vacina multivalente.
AU6217798A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
GB2337755B (en) Virus vaccine
ZA975618B (en) Avian recombinant live vaccine using as vector the avian infectious laryngotrachetis virus
DK1094837T3 (da) Porcin circovirus og parvovirusvaccine
CY2016018I1 (el) Εμβολιο κατα του ιου του δυτικου νειλου
PL398575A1 (pl) Kompozycja szczepionki przeciwko zakażeniu wirusem Zachodniego Nilu
ZA200210230B (en) Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.
BR0010418B1 (pt) microorganismo de salmonella, composiÇço de vacina e uso do referido microorganismo.
ATE300949T1 (de) Ssa inaktivierte salmonella impfstoffe
DZ2283A1 (fr) Composition de vaccin.
IL158428A0 (en) Vaccine composition comprising at least one hiv virus antigen
BR9915703B1 (pt) mutante do vìrus da raiva recombinante, e, vacina anti-rábica atenuada viva.
AU2002307971A1 (en) Vaccine against the nile fever virus
EP1749885B8 (en) Infectious and attenuated bovine viral diarrhea virus vaccine
MXPA03002875A (es) Composicion de vacuna y metodo de estabilizacion.
PT1253197E (pt) Virus da raiva recombinante atenuado e suas vacinas vivas
IS6184A (is) Bóluefni gegn ISA veiru
HUP0401182A3 (en) Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
ATE333894T1 (de) Vakzine gegen infektiöse bursitis
AU3487799A (en) Improved live attenuated viruses for use as vectors or vaccines
IL149173A0 (en) Attenuated recombinant rabies virus mutants and live vaccines thereof
AU2002314610A1 (en) Attenuated very virulent infectious bursal disease virus

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]

Free format text: O DEFERIMENTO DO PRESENTE PEDIDO DEVE SER RESSALVADO NO QUE INCIDIR NO ARTIGO 10, INCISO IX, DA LEI 9279, DE 14 DE MAIO DE 1996.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/09/2012, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)